
Scott A. Rogers
Examiner (ID: 604, Phone: (571)272-7467 , Office: P/2673 )
| Most Active Art Unit | 2625 |
| Art Unit(s) | 2626, 2853, 2108, 2724, 2624, 2899, 2612, 2672, 2676, 2616, 2673, 2683, 2721, 2106, 2627, 2625, 2681 |
| Total Applications | 3084 |
| Issued Applications | 2795 |
| Pending Applications | 128 |
| Abandoned Applications | 187 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13925951
[patent_doc_number] => 20190046491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => OXIDATIVE RETINAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/106838
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16106838
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/106838 | Oxidative retinal diseases | Aug 20, 2018 | Issued |
Array
(
[id] => 13590645
[patent_doc_number] => 20180346871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => Compositions and methods for activation and overexpression of secondary metabolites in microorganisms
[patent_app_type] => utility
[patent_app_number] => 16/059258
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059258
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/059258 | Compositions and methods for activation and overexpression of secondary metabolites in microorganisms | Aug 8, 2018 | Issued |
Array
(
[id] => 16236799
[patent_doc_number] => 20200254033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => COMPOSITION FOR PREVENTING AND IMPROVING GASTROINTESTINAL DISORDER CONTAINING LACTOBACILLUS PLANTARUM
[patent_app_type] => utility
[patent_app_number] => 16/647250
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647250
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647250 | COMPOSITION FOR PREVENTING AND IMPROVING GASTROINTESTINAL DISORDER CONTAINING LACTOBACILLUS PLANTARUM | Aug 8, 2018 | Abandoned |
Array
(
[id] => 18086605
[patent_doc_number] => 11536734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Method and particle analyzer for measuring a low concentration particle sample
[patent_app_type] => utility
[patent_app_number] => 16/052965
[patent_app_country] => US
[patent_app_date] => 2018-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 4271
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16052965
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/052965 | Method and particle analyzer for measuring a low concentration particle sample | Aug 1, 2018 | Issued |
Array
(
[id] => 15454997
[patent_doc_number] => 20200040323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => Urease Purification And Purified Urease Products Thereof And Sorbent Cartridges, Systems And Methods Using The Same
[patent_app_type] => utility
[patent_app_number] => 16/049954
[patent_app_country] => US
[patent_app_date] => 2018-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16049954
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/049954 | Urease Purification And Purified Urease Products Thereof And Sorbent Cartridges, Systems And Methods Using The Same | Jul 30, 2018 | Abandoned |
Array
(
[id] => 13590601
[patent_doc_number] => 20180346849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => PRODUCT AND METHOD FOR REMOVAL OF BIOFILMS
[patent_app_type] => utility
[patent_app_number] => 16/044309
[patent_app_country] => US
[patent_app_date] => 2018-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16044309
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/044309 | Product and method for removal of biofilms | Jul 23, 2018 | Issued |
Array
(
[id] => 16153873
[patent_doc_number] => 20200215169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => ANTIBACTERIAL METHODS AND RELATED KITS
[patent_app_type] => utility
[patent_app_number] => 16/631225
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16631225
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/631225 | ANTIBACTERIAL METHODS AND RELATED KITS | Jul 16, 2018 | Abandoned |
Array
(
[id] => 15960505
[patent_doc_number] => 20200164004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => BACTERIAL COMPOSITION AND/OR DERIVATIVES THEREOF WHOSE BIOLOGICAL ACTIVITY HAS BEEN SPECIFICALLY STUDIED FOR THE IMPROVEMENT OF THE STATE OF HEALTH DIFFERENTIATED FOR MALES AND FEMALES
[patent_app_type] => utility
[patent_app_number] => 16/624249
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624249
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/624249 | BACTERIAL COMPOSITION AND/OR DERIVATIVES THEREOF WHOSE BIOLOGICAL ACTIVITY HAS BEEN SPECIFICALLY STUDIED FOR THE IMPROVEMENT OF THE STATE OF HEALTH DIFFERENTIATED FOR MALES AND FEMALES | Jun 18, 2018 | Abandoned |
Array
(
[id] => 13504735
[patent_doc_number] => 20180303910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/012555
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16012555
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/012555 | METHODS AND COMPOSITIONS FOR TREATING DISEASES | Jun 18, 2018 | Abandoned |
Array
(
[id] => 16837886
[patent_doc_number] => 20210145898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => MUSCLE-MODIFYING AGENT
[patent_app_type] => utility
[patent_app_number] => 16/617077
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617077
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617077 | MUSCLE-MODIFYING AGENT | May 24, 2018 | Abandoned |
Array
(
[id] => 15738393
[patent_doc_number] => 20200108084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => COMPOSITION COMPRISING OLIGOFRUCTOSE (OF) FOR USE IN THE IMPROVEMENT OF SHORT TERM MEMORY AND OTHER COGNITIVE BENEFITS
[patent_app_type] => utility
[patent_app_number] => 16/615597
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615597 | COMPOSITION COMPRISING OLIGOFRUCTOSE (OF) FOR USE IN THE IMPROVEMENT OF SHORT TERM MEMORY AND OTHER COGNITIVE BENEFITS | May 23, 2018 | Abandoned |
Array
(
[id] => 13574953
[patent_doc_number] => 20180339025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => ENZYME COMPOSITION FOR MANAGEMENT OF METABOLIC HEALTH
[patent_app_type] => utility
[patent_app_number] => 15/986854
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15986854
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/986854 | ENZYME COMPOSITION FOR MANAGEMENT OF METABOLIC HEALTH | May 22, 2018 | Abandoned |
Array
(
[id] => 16571046
[patent_doc_number] => 20210010052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => MARKER AND METHOD FOR DETERMINATION OF PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/612968
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7234
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612968
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612968 | Marker and method for determination of Parkinson's disease | May 16, 2018 | Issued |
Array
(
[id] => 13548519
[patent_doc_number] => 20180325807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => METHOD AND APPARATUS FOR APPLYING A PHARMACEUTICAL AGENT TO REDUCE POST-SURGICAL ADHESIONS
[patent_app_type] => utility
[patent_app_number] => 15/977809
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15977809
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/977809 | METHOD AND APPARATUS FOR APPLYING A PHARMACEUTICAL AGENT TO REDUCE POST-SURGICAL ADHESIONS | May 10, 2018 | Abandoned |
Array
(
[id] => 16196818
[patent_doc_number] => 10721954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Antioxidant producing bacterium and uses therof
[patent_app_type] => utility
[patent_app_number] => 15/971406
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 23
[patent_no_of_words] => 16894
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15971406
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/971406 | Antioxidant producing bacterium and uses therof | May 3, 2018 | Issued |
Array
(
[id] => 15764319
[patent_doc_number] => 20200113177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => COMPOSITIONS AND METHODS FOR THE ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS
[patent_app_type] => utility
[patent_app_number] => 16/606601
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -75
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606601
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606601 | Compositions and methods for the encapsulation and scalable delivery of agrochemicals | Apr 29, 2018 | Issued |
Array
(
[id] => 18576612
[patent_doc_number] => 11733131
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Tissue slice selection method, and embedded block preparing cassette
[patent_app_type] => utility
[patent_app_number] => 16/609074
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 21
[patent_no_of_words] => 22760
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609074 | Tissue slice selection method, and embedded block preparing cassette | Apr 26, 2018 | Issued |
Array
(
[id] => 16761079
[patent_doc_number] => 20210106660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => BOTULINUM NEUROTOXINS FOR TREATING HYPERHIDROSIS
[patent_app_type] => utility
[patent_app_number] => 16/606430
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606430
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606430 | BOTULINUM NEUROTOXINS FOR TREATING HYPERHIDROSIS | Apr 19, 2018 | Abandoned |
Array
(
[id] => 15451337
[patent_doc_number] => 20200038492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => INITIATING NEUROTOXIN TREATMENTS
[patent_app_type] => utility
[patent_app_number] => 16/606866
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606866
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606866 | INITIATING NEUROTOXIN TREATMENTS | Apr 19, 2018 | Abandoned |
Array
(
[id] => 13457807
[patent_doc_number] => 20180280446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => Agent for Treating Urinary Incontinence Including Stem Cells Derived from Amniotic Fluid
[patent_app_type] => utility
[patent_app_number] => 15/944579
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15944579
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/944579 | Agent for Treating Urinary Incontinence Including Stem Cells Derived from Amniotic Fluid | Apr 2, 2018 | Abandoned |